ANIX News and Press, Anixa Biosciences Inc.

Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology PR Newswire SAN JOSE, Calif. , July 17, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment an...

2024-07-15 08:43:07 ET More on Anixa Biosciences Seeking Alpha’s Quant Rating on Anixa Biosciences Read the full article on Seeking Alpha For further details see: Anixa Biosciences authorizes $5M share buyback program

Anixa Biosciences Announces $5 Million Share Repurchase Program PR Newswire SAN JOSE, Calif. , July 15, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of ...

Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial PR Newswire This patient is expected to be the final patient in the second dosage cohort of the trial SAN JOSE, Calif. , June 24, 2024 /PRNewswire/ -- Anixa Biosciences, I...

2024-06-10 07:30:03 ET H.C. Wainwright analyst issues BUY recommendation for ANIX on June 10, 2024 06:07AM ET. The previous analyst recommendation was Buy. ANIX was trading at $2.55 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ...

2024-05-28 06:10:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the oldest maxims in investing is that higher risk produces greater returns. That maxim holds particularly true across penny biotech stocks. Developing therapeutics to cure diseases ...

Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial PR Newswire Novel and proprietary CAR-T approach holds potential to be first effective CAR-T therapy for solid tumors SAN JOSE, Calif. , May 21, 2024 /PRNewswire...

Anixa Biosciences (NASDAQ: ANIX) is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. Anixa's therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of ...

2024-05-08 08:55:42 ET More on Anixa Biosciences Seeking Alpha’s Quant Rating on Anixa Biosciences Historical earnings data for Anixa Biosciences Financial information for Anixa Biosciences Read the full article on Seeking Alpha For further det...

Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines PR Newswire – Company currently collaborates with Cleveland Clinic on breast cancer and ovarian cancer vaccines – SAN JOSE, Calif. , May 8, 2024 ...